GYRE THERAPEUTICS, INC.

Other languages Gyre Therapeutics, Inc.

Equities

GYRE

US4037831033

End-of-day quote Nasdaq Other stock markets 18:00:00 2024-06-13 EDT			5-day change	1st Jan Change
11.04 ^USD	0.00%		-0.45%	-57.03%

05-31	Gyre Therapeutics Gets Investigational New Drug Application Approval in China for Pulmonary Arterial Hypertension Therapy	MT
05-30	Gyre Pharmaceuticals Receives IND Approval from China?s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Gyre Therapeutics Gets Investigational New Drug Application Approval in China for Pulmonary Arterial Hypertension Therapy	05-31
Gyre Pharmaceuticals Receives IND Approval from China?s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension	05-30
Gyre Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09
Gyre Therapeutics Insider Sold Shares Worth $323,000, According to a Recent SEC Filing	04-03
Gyre Therapeutics Swings to Fiscal 2023 Net Loss, Revenue Rises	03-26
Gyre Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-26
Gyre Therapeutics Announces Appointment of Rodney L. Nussbaum to the Board of Directors and Member of Audit Committee	03-21
Gyre Therapeutics, Inc. Announces Board Changes	01-19
Gyre Therapeutics, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	01-12
Gyre Therapeutics, Inc. Announces CEO Changes, Effective January 15, 2024	12-15
Gyre Therapeutics, Inc. and Beijing Continent Pharmaceuticals Co., Ltd. Announce the Resignation of Charles Wu as Member of the Board of Directors. Effective on January 15, 2024	12-15
Gyre Therapeutics, Inc. Announces Management Changes	23-10-30
Gyre Therapeutics, Inc. Announces Management Changes	23-10-30
Gyre Therapeutics, Inc. Announces CEO Changes	23-10-30
Gyre Therapeutics, Inc. Announces Management Changes	23-10-30
Gyre Therapeutics, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer